Kaplan–Meier survival analysis indicated that HCC patients with high SLC7A11 expression levels tended to have a shorter disease‐free survival (DFS) and overall survival (OS) compared to those with low SLC7A11 expression (Figure 1C,D). Here, SLC7A11 is linked to hepatocellular carcinoma.